A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...
Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...
Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.
Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.
Though most people recover from the gastrointestinal illness within three days, norovirus is annually responsible for 465,000 emergency department visits, mostly in young children; 109,000 ...
Moderna’s mRNA-1403 is a messenger RNA-based ... disease and foodborne illness in the US and can severely affect young children (under 5 years), older adults, and immunocompromised individuals.